tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Imugene Extends Share Purchase Plan Deadline
Company AnnouncementsImugene Extends Share Purchase Plan Deadline
7d ago
Imugene Extends Share Purchase Plan Deadline to Enhance Shareholder Participation
PremiumCompany Announcements
Imugene Extends Share Purchase Plan Deadline to Enhance Shareholder Participation
8d ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
PremiumCompany Announcements
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial
15d ago
Imugene Issues Over 68 Million Shares to Fund Immunotherapy Advancements
PremiumCompany Announcements
Imugene Issues Over 68 Million Shares to Fund Immunotherapy Advancements
26d ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
26d ago
Imugene Limited Announces Director’s Interest Change
PremiumCompany AnnouncementsImugene Limited Announces Director’s Interest Change
27d ago
Imugene Limited Expands Market Presence with New Securities Quotation
Premium
Company Announcements
Imugene Limited Expands Market Presence with New Securities Quotation
27d ago
Imugene Announces Extraordinary General Meeting for 2025
Premium
Company Announcements
Imugene Announces Extraordinary General Meeting for 2025
29d ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
1M ago
Imugene to Host Webinar on Azer-cel Phase 1b Trial Data
PremiumCompany Announcements
Imugene to Host Webinar on Azer-cel Phase 1b Trial Data
1M ago
Imugene Limited Announces Share and Options Offer to Raise $37.5 Million
PremiumCompany Announcements
Imugene Limited Announces Share and Options Offer to Raise $37.5 Million
1M ago
Imugene Limited Announces Capital Raising for Cancer Treatment Innovations
PremiumCompany Announcements
Imugene Limited Announces Capital Raising for Cancer Treatment Innovations
1M ago
Imugene Limited Announces Proposed Securities Issue to Support Cancer Immunotherapy Research
PremiumCompany AnnouncementsImugene Limited Announces Proposed Securities Issue to Support Cancer Immunotherapy Research
1M ago
Imugene Limited Announces Proposed Securities Issue to Bolster Cancer Immunotherapy Efforts
Premium
Company Announcements
Imugene Limited Announces Proposed Securities Issue to Bolster Cancer Immunotherapy Efforts
1M ago
Imugene Secures $22.5M in Funding, Launches $15M Share Purchase Plan
Premium
Company Announcements
Imugene Secures $22.5M in Funding, Launches $15M Share Purchase Plan
1M ago
Imugene Limited Initiates Trading Halt for Capital Raising Announcement
PremiumCompany Announcements
Imugene Limited Initiates Trading Halt for Capital Raising Announcement
1M ago
Imugene Reports Positive Results in Phase 1b CAR T Trial for DLBCL
PremiumCompany Announcements
Imugene Reports Positive Results in Phase 1b CAR T Trial for DLBCL
1M ago
Imugene Secures $5.8 Million R&D Tax Refund to Advance Cancer Therapies
PremiumCompany Announcements
Imugene Secures $5.8 Million R&D Tax Refund to Advance Cancer Therapies
2M ago
Imugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
PremiumCompany Announcements
Imugene Initiates Phase II Trial for PD1-Vaxx in Colorectal Cancer
2M ago
Imugene’s Resolutions Passed at Extraordinary General Meeting
PremiumCompany AnnouncementsImugene’s Resolutions Passed at Extraordinary General Meeting
2M ago
Imugene Advances Cancer Therapy Development with Promising Results
Premium
Company Announcements
Imugene Advances Cancer Therapy Development with Promising Results
2M ago
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
Premium
Company Announcements
Imugene Secures US Patent for Oncolytic Virotherapy, Strengthening Global IP Position
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >